Cited by 272Cardiovascular Syncope and Autonomic DisordersHeart Failure Treatment and ManagementEmergency and Acute Care Studies

The ROSE (Risk Stratification of Syncope in the Emergency Department) Study

Open access
Reed, Matthew J., Newby, David E., Coull, Andrew J., Prescott, Robin J., Jacques, Keith G., Gray, Alasdair J.·2010·Journal of the American College of Cardiology

Abstract

Objectives The aim of this study was to develop and validate a clinical decision rule (CDR) to predict 1-month serious outcome and all-cause death in patients presenting with syncope to the emergency department.Background Syncope is a common, potentially serious condition accounting for many hospital admissions.Methods This was a single center, prospective, observational study of adults presenting to the emergency department with syncope. A CDR was devised from 550 patients in a derivation cohort and tested in a validation cohort of a further 550 patients.Results One-month serious outcome or all-cause death occurred in 40 (7.3%) patients in the derivation cohort. Independent predictors were brain natriuretic peptide concentration > or =300 pg/ml (odds ratio [OR]: 7.3), positive fecal occult blood (OR: 13.2), hemoglobin < or =90 g/l (OR: 6.7), oxygen saturation < or =94% (OR: 3.0), and Q-wave on the presenting electrocardiogram (OR: 2.8). One-month serious outcome or all-cause death occurred in 39 (7.1%) patients in the validation cohort. The ROSE (Risk stratification Of Syncope in the Emergency department) rule had a sensitivity and specificity of 87.2% and 65.5%, respectively, and a negative predictive value of 98.5%. An elevated B-type natriuretic peptide (BNP) concentration alone was a major predictor of serious cardiovascular outcomes (8 of 22 events, 36%) and all-cause deaths (8 of 9 deaths, 89%).Conclusions The ROSE rule has excellent sensitivity and negative predictive value in the identification of high-risk patients with syncope. As a component, BNP seems to be a major predictor of serious cardiovascular outcomes and all-cause death. The ROSE rule and BNP measurement might be valuable risk stratification tools in patients with emergency presentations of syncope and should now be subjected to external validation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.09.049

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • None of the different risk stratification tools developed and tested so far have definitely proved to perform better than clinical judgment.

    “Different risk stratification tools have been developed and tested so far but none have definitely proved to perform better than clinical judgment. 1,9,13,14”

    From Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency department (2016) · cites this paper as [14]

    The Conclusions describe several syncope risk-stratification studies and note limitations in their validation. The ROSE Study section says a decision rule should be used alongside physician judgment, but the paper does not establish the broader claim that no tool has proved better than clinical judgment. Page numbers are not supplied for these passages. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • The ROSE rule performed suboptimally when validated and requires B-type natriuretic peptide testing, which is not easily available in many emergency departments.

    “The rule performed suboptimally when validated and requires B-type natriuretic peptide testing, which is not easily available in many emergency departments.”

    From Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope (2016) · cites this paper as [9]

    The ROSE rule (Discussion; page not specified) includes a BNP threshold, and the paper says only 5% of UK emergency departments had point-of-care BNP testing. The validation results (Performance of the ROSE rule; page not specified) report five missed patients, but the authors describe the rule’s sensitivity as excellent, say external validation was still needed, and note that almost all UK emergency departments had rapid access to laboratory BNP. The paper therefore does not fully support the characterization of validated performance as suboptimal or BNP testing as generally difficult to obtain. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Inclusion of patients with serious adverse events identified in the emergency department introduces bias in the tool.

    “Inclusion of patients with serious adverse events identified in the emergency department introduces bias in the tool”

    From Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope (2016) · cites this paper as [9]

    The ROSE Study section reports that patients whose serious outcomes were apparent at initial ED assessment were included, and says the rule should be applied when a clear diagnosis is not apparent. It does not state that including those patients introduced bias into the tool. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Many (40-45%) non-cardiovascular and some cardiovascular life-threatening underlying conditions are obvious in the ED.

    “Many (40-45%) non-cardiovascular and some cardiovascular life-threatening underlying conditions are obvious in the ED. 44”

    From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [44]

    Table 2 in the Discussion reports an obvious diagnosis in the ED for 17 of 40 patients with a primary outcome in the derivation cohort and 16 of 39 in the validation cohort—about 40–45%. Those figures cover serious outcomes or death overall; the table does not establish that 40–45% of non-cardiovascular conditions, specifically, were obvious or show how many obvious diagnoses were cardiovascular. The indexed passage does not provide a page number. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • From 7% to 23% of patients with syncope will experience a serious adverse event within 7-30 days, with about half being evident only after disposition from the emergency department, either while admitted in hospital or after discharge home.

    “From 7% to 23% of patients with syncope will experience a serious adverse event within 7-30 days, with about half being evident only after disposition from the emergency department, either while admitted in hospital or after discharge home. 7-9”

    From Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope (2016) · cites this paper as [9]

    The Results report a serious outcome or death within one month in 7.3% of the derivation cohort and 7.1% of the validation cohort. The outcome table in the Discussion records an obvious diagnosis in the ED for 17 of 40 and 16 of 39 patients with primary outcomes, consistent with roughly half not being obvious there. The paper does not establish the claimed 23% upper rate or show that those outcomes first became evident only after ED disposition, whether in hospital or at home. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [15]15. Brignole M, Alboni P, Benditt DG, et al., Task Force on Syncope, European Society of Cardiology. Guidelines on management (diag- nosis and treatment) of syncope-update 2004: executive summary. Eur Heart J 2004;25:2054 -72.
  2. [20]20. Reed MJ, Newby DE, Coull AJ, et al. Near-patient BNP is able to predict three-month serious outcome in adult syncope patients pre- senting to the Emergency Department. Emerg Med J 2007;24:769 -73
  3. [27]27. Linzer M, Yang EH, Estes NA III, et al. Diagnosing syncope. 1. Value of history, physical examination, and electrocardiography: Clin- ical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;126:989 -96.
  4. [28]28. Linzer M, Yang EH, Estes NA III, et al. Diagnosing syncope. 2. Unexplained syncope: Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;127:76 -86.

Cited by

Sorted by citations

Authors
Reed, M. J., Newby, D. E., Coull, A. J., Prescott, R. J., Jacques, K. G., & Gray, A. J.
Affiliations
  • Edinburgh Royal Infirmary (GB)
  • University of Edinburgh (GB)
Corresponding author
Reed, Matthew J.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2010-02
Volume
55
Issue
8
Pages
713-721
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2092319060
Cited by
272
References
28
Citations by year
2026: 6 · 2025: 10 · 2024: 7 · 2023: 13 · 2022: 4 · 2021: 15 · 2020: 18 · 2019: 17 · 2018: 32 · 2017: 22 · 2016: 17 · 2015: 16 · 2014: 32 · 2013: 27 · 2012: 16
FWCI
21.23
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Emergency Medicine › Emergency and Acute Care Studies
Keywords
syncope, clinical decision rules, risk stratification, brain natriuretic peptide, all-cause mortality, fecal occult blood, hemoglobin, oxygen saturation, Q waves, emergency department, cardiovascular risk prediction
MeSH terms
Adult, Aged, Cause of Death, Emergency Service, Hospital, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Risk Factors, Sensitivity and Specificity, Syncope, Reproducibility of Results, Risk Assessment, Decision Support Systems, Clinical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review